Compound ID | 16
Bacteriocin LU11
Class: Antimicrobial peptide
| Agent Type: | Indirect acting; |
| Spectrum of activity: | Gram-negative |
| Mechanism of action: | Class A beta-lactamase inhibitor |
| Target Pathogen: | Active against Pseudomonas aeruginosa, Acinetobacter baumannii, Escherichia coli, and Salmonella spp. |
| Combined with other compounds: | Yes |
| Institute where first reported: | North Eastern Hill Univeristy, India |
| Year first mentioned: | 2014 |
| Development status: | Experimental |
| External links: | |
| Citation: | https://patents.google.com/patent/US8927252B2/en |
| Patent: | US8927252B2 |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.